Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease

References

• Aier, I., Varadwaj, P. K., & Raj, U. (2016). Structural insights into conformational stability of both wild-type and mutant EZH2 receptor. Scientific Reports, 6(1), 34984.Mismatch]
   PubMed Web of Science ®Google Scholar
• Al-Khodairy, F. M., Khan, M. K., Kunhi, M., Pulicat, M. S., Akhtar, S., & Arif, J. M. (2013). In Silico prediction of mechanism of Erysolin-induced apoptosis in human breast cancer cell lines. American Journal of Bioinformatics Research, 3, 62–71.
   Google Scholar
• Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450–452.
   PubMed Web of Science ®Google Scholar
• Ardalan, M. R., & Rafieian-Kopaei, M. (2013). Is the safety of herbal medicines for kidneys under question? Journal of Nephropharmacology, 2(2), 11–12.
   PubMedGoogle Scholar
• Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020). Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Computational and Structural Biotechnology Journal, 18, 784–790. https://doi.org/https://doi.org/10.1016/j.csbj.2020.03.025
   PubMed Web of Science ®Google Scholar
• Bekhit, A. E., & Bekhit, A. A. Natural antiviral compounds. In Studies in natural products chemistry. 2014 Jan 1. (Vol. 42, pp. 195–228). Elsevier.
   Google Scholar
• Benet, L. Z., Hosey, C. M., Ursu, O., & Oprea, T. I. (2016). BDDCS, the rule of 5 and drugability. Advanced Drug Delivery Reviews, 101, 89–98.
   PubMed Web of Science ®Google Scholar
• Benfenati, E., Benigni, R., Demarini, D. M., Helma, C., Kirkland, D., Martin, T. M., Mazzatorta, P., Ouédraogo-Arras, G., Richard, A. M., Schilter, B., Schoonen, W. G. E. J., Snyder, R. D., & Yang, C. (2009). Predictive models for carcinogenicity and mutagenicity: Frameworks, state-of-the-art, and perspectives. Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews, 27(2), 57–90.
   PubMed Web of Science ®Google Scholar
• Beura, S., & Prabhakar, C. (2020). In-silico strategies for probing chloroquine based inhibitors against SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–25.
   Web of Science ®Google Scholar
• Boopathi, S., Poma, A. B., & Kolandaivel, P. (2020). Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, 29, 1–10.
   Web of Science ®Google Scholar
• Bosch, B. J., van der Zee, R., de Haan, C. A., & Rottier, P. J. (2003). The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex. Journal of Virology, 77(16), 8801–8811.
   PubMed Web of Science ®Google Scholar
• Brandman, R., Brandman, Y., & Pande, V. S. (2012). A-site residues move independently from P-site residues in all-atom molecular dynamics simulations of the 70S bacterial ribosome. PloS One, 7(1), e29377.
   PubMed Web of Science ®Google Scholar
• Cao, D., Wang, J., Zhou, R., Li, Y., Yu, H., & Hou, T. (2012). ADMET evaluation in drug discovery. 11. PharmacoKinetics Knowledge Base (PKKB): A comprehensive database of pharmacokinetic and toxic properties for drugs. Journal of Chemical Information and Modeling, 52(5), 1132–1137.
   PubMed Web of Science ®Google Scholar
• Carvalho, O. V., Botelho, C. V., Ferreira, C. G. T., Ferreira, H. C. C., Santos, M. R., Diaz, M. A. N., Oliveira, T. T., Soares-Martins, J. A. P., Almeida, M. R., & Silva, A. (2013). In vitro inhibition of canine distemper virus by flavonoids and phenolic acids: Implications of structural differences for antiviral design. Research in Veterinary Science, 95(2), 717–724.
   PubMed Web of Science ®Google Scholar
• Cereto-Massagué, A., Guasch, L., Valls, C., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2012). DecoyFinder: An easy-to-use python GUI application for building target-specific decoy sets. Bioinformatics (Oxford, England)), 28(12), 1661–1662.
   PubMed Web of Science ®Google Scholar
• Chen, C. N., Lin, C. P., Huang, K. K., Chen, W. C., Hsieh, H. P., Liang, P. H., & Hsu, J. T. (2005). Inhibition of SARS-CoV 3C-like protease activity by Theaflavin-3,3'-digallate (TF3) ). Evidence-Based Complementary and Alternative Medicine :Ecam, 2(2), 209–215.
   PubMed Web of Science ®Google Scholar
• Chen, H., Muhammad, I., Zhang, Y., Ren, Y., Zhang, R., Huang, X., Diao, L., Liu, H., Li, X., Sun, X., Abbas, G., & Li, G. (2019). Antiviral activity against infectious bronchitis virus and bioactive components of Hypericum perforatum L. Frontiers in Pharmacology, 10, 1272.
   PubMed Web of Science ®Google Scholar
• Chowdhury, P., Sahuc, M. E., Rouillé, Y., Vandeputte, A., Brodin, P., Goswami, M., Bandyopadhyay, T., Dubuisson, J., & Seron, K. (2018). Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus. BioRxiv, 325126.
   Google Scholar
• da Silva, J. A. (2020). Convalescent plasma: A possible treatment of COVID-19 in India. Medical Journal Armed Forces India, 76(2), 236–237.
   PubMedGoogle Scholar
• Daina, A., & Zoete, V. (2016). A BOILED-egg to predict gastrointestinal absorption and brain penetration of small molecules . ChemMedChem., 11(11), 1117–1121.
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2014). iLOGP: A simple, robust, and efficient description of n-octanol/water partition coefficient for drug design using the GB/SA approach . Journal of Chemical Information and Modeling, 54(12), 3284–3301. Dec 22
   PubMed Web of Science ®Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717.
   PubMed Web of Science ®Google Scholar
• Dang, V. T., Benkendorff, K., & Speck, P. (2011). In vitro antiviral activity against herpes simplex virus in the abalone Haliotis laevigata. Journal of General Virology, 92(3), 627–637. https://doi.org/https://doi.org/10.1099/vir.0.025247-0
   PubMed Web of Science ®Google Scholar
• Das, S., Sarmah, S., Lyndem, S., & Roy, S. (2020). A. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 30, 1–8.
   Web of Science ®Google Scholar
• Dawood, F. S., Jain, S., Finelli, L., Shaw, M. W., Lindstrom, S., Garten, R. J., Gubareva, L. V., Xu, X., Bridges, C. B., & Uyeki, T. M. (2009). Emergence of a novel swine-origin influenza A (H1N1) virus in humans. The New England Journal of Medicine, 360(25), 2605–2615. https://doi.org/https://doi.org/10.1056/NEJMoa0903810
   PubMed Web of Science ®Google Scholar
• De Oliveira, A., Prince, D., Lo, C. Y., Lee, L. H., & Chu, T. C. (2015). Antiviral activity of theaflavin digallate against herpes simplex virus type 1. Antiviral Research, 118, 56–67.
   PubMed Web of Science ®Google Scholar
• Ding, Y., Chen, B., Gao, Z., Suo, H., & Xiao, H. (2017). Pre-treated theaflavin-3,3'-digallate has a higher inhibitory effect on the HCT116 cell line . Food & Nutrition Research, 61(1), 1400340.
   PubMed Web of Science ®Google Scholar
• Ding, Y., Chen, B., Suo, H., & Tong, H. (2020). The enzyme‐oriented regulation of theaflavin‐3, 3′‐digallate synthesis and the accurate determination of its yield. International Journal of Food Science & Technology, 55(4), 1531–1538. https://doi.org/https://doi.org/10.1111/ijfs.14429
   Web of Science ®Google Scholar
• Elfiky, A. A. (2020). Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS- CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study. Life Sciences, 253, 117592. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117592
   PubMed Web of Science ®Google Scholar
• Forli, S., Huey, R., Pique, M. E., Sanner, M. F., Goodsell, D. S., & Olson, A. J. (2016). Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols, 11(5), 905–919.
   PubMed Web of Science ®Google Scholar
• Ganeshpurkar, A., & Saluja, A. K. (2017). The pharmacological potential of rutin. Saudi Pharmaceutical Journal : SPJ: The Official Publication of the Saudi Pharmaceutical Society, 25(2), 149–164.
   PubMed Web of Science ®Google Scholar
• Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., Zhang, Y.-J., Luo, C.-M., Tan, B., Wang, N., Zhu, Y., Crameri, G., Zhang, S.-Y., Wang, L.-F., Daszak, P., & Shi, Z.-L. (2013). Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor . Nature, 503(7477), 535–538.
   PubMed Web of Science ®Google Scholar
• Gentile, D., Patamia, V., Scala, A., Sciortino, M. T., Piperno, A., & Rescifina, A. (2020). Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: A virtual screening and molecular modeling study. Marine Drugs, 18(4), 225. https://doi.org/https://doi.org/10.3390/md18040225
   PubMed Web of Science ®Google Scholar
• Grubaugh, N. D., Faria, N. R., Andersen, K. G., & Pybus, O. G. (2018). Genomic insights into Zika virus emergence and spread. Cell, 172(6), 1160–1162.
   PubMed Web of Science ®Google Scholar
• Gupta, M. K., Vemula, S., Donde, R., Gouda, G., Behera, L., & Vadde, R. (2020). In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. Journal of Biomolecular Structure and Dynamics, 13, 1–11.
   Web of Science ®Google Scholar
• Hagar, M., Ahmed, H. A., Aljohani, G., & Alhaddad, O. A. (2020). Investigation of some antiviral N-heterocycles as COVID 19 drug: Molecular docking and DFT calculations. International Journal of Molecular Sciences, 21(11), 3922. Janhttps://doi.org/https://doi.org/10.3390/ijms21113922
   PubMed Web of Science ®Google Scholar
• Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006). Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor. Virology, 350(1), 15–25.
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. 12https://doi.org/https://doi.org/10.1021/acs.jctc.5b00864
   PubMed Web of Science ®Google Scholar
• Hatada, R., Okuwaki, K., Mochizuki, Y., Fukuzawa, K., Komeiji, Y., Okiyama, Y., & Tanaka, S. (2020). Fragment molecular orbital based interaction analyses on COVID-19 main protease- inhibitor N3 complex (PDB ID: 6LU7). ChemRxiv. ( https://doi.org/https://doi.org/10.26434/chemrxiv.11988120.v1)
   Google Scholar
• Hayashi, K. Y., Hayashi, T., & Morita, N. (1992). Mechanism of action of the antiherpesvirus biflavone ginkgetin. Antimicrobial Agents and Chemotherapy, 36(9), 1890–1893.
   PubMed Web of Science ®Google Scholar
• He, Y., Zhu, Q., Chen, M., Huang, Q., Wang, W., Li, Q., Huang, Y., & Di, W. (2016). The changing 50% inhibitory concentration (IC50) of cisplatin: A pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer. Oncotarget, 7(43), 70803–70821. Oct 25
   PubMedGoogle Scholar
• Hibasami, H., Jin, Z. X., Yoshioka, K., Ina, K., & Ohnishi, K. (2004). Human colon cancer cells undergo apoptosis by theaflavin digallate, epigallocatechin gallate, and oolong tea polyphenol extract. Journal of Herbs, Spices & Medicinal Plants, 10(4), 29–38. https://doi.org/https://doi.org/10.1300/J044v10n04_04
   Google Scholar
• Hollingsworth, S. A., & Dror, R. O. (2018). Molecular dynamics simulation for all. Neuron, 99(6), 1129–1143.
   PubMed Web of Science ®Google Scholar
• Hospital, A., Goñi, J. R., Orozco, M., & Gelpí, J. L. (2015). Molecular dynamics simulations: Advances and applications. Advances and Applications in Bioinformatics and Chemistry: AABC, 8, 37–47. https://doi.org/https://doi.org/10.2147/AABC.S70333
   PubMedGoogle Scholar
• Huang, B. (2009). MetaPocket: A meta approach to improve protein ligand binding site prediction. Omics: A Journal of Integrative Biology, 13(4), 325–330.
   PubMed Web of Science ®Google Scholar
• Huang, F., & Nau, W. M. (2003). A conformational flexibility scale for amino acids in peptides. Angewandte Chemie (International ed. in English)), 42(20), 2269–2272.
   PubMed Web of Science ®Google Scholar
• Huang, N., Shoichet, B. K., & Irwin, J. J. (2006). Benchmarking sets for molecular docking. Journal of Medicinal Chemistry, 49(23), 6789–6801.
   PubMed Web of Science ®Google Scholar
• Ibrahim, M. T., Uzairu, A., Shallangwa, G. A., & Uba, S. (2020). In-silico activity prediction and docking studies of some 2, 9-disubstituted 8-phenylthio/phenylsulfinyl-9h-purine derivatives as Anti-proliferative agents. Heliyon, 6(1), e03158.
   PubMed Web of Science ®Google Scholar
• Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A A. (2020). Molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 7, 1–12.
   Web of Science ®Google Scholar
• Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., Pruijssers, A. J. & An, (2020). mRNA vaccine against SARS-CoV-2—Preliminary report. New England Journal of Medicine.
   Web of Science ®Google Scholar
• Jo, S., Kim, S., Shin, D. H., & Kim, M. S. (2020). Inhibition of SARS-CoV 3CL protease by flavonoids. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 145–151.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., & Tirado-Rives, J. (1988). The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. Journal of the American Chemical Society, 110(6), 1657–1666.
   PubMed Web of Science ®Google Scholar
• Joshi, T., Joshi, T., Sharma, P., Chandra, S., & Pande, V. (2020). Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of Xanthomonas oryzae pv. Oryzae by targeting peptide deformylase. Journal of Biomolecular Structure and Dynamics, 1–8.
   Web of Science ®Google Scholar
• Keivan, Z., Teoh, B. T., Sam, S. S., Wong, P. F., Mustafa, M. R., & AbuBakar, S. (2014). In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2. Journal of Medicinal Plants Research, 8(6), 307–309. https://doi.org/https://doi.org/10.5897/JMPR11.1046 [InsertedFromOnline
   Google Scholar
• Kernan, M. R., Sendl, A., Chen, J. L., Jolad, S. D., Blanc, P., Murphy, J. T., Stoddart, C. A., Nanakorn, W., Balick, M. J., & Rozhon, E. J. (1997). Two new lignans with activity against influenza virus from the medicinal plant Rhinacanthus nasutus. Journal of Natural Products, 60(6), 635–637.
   PubMed Web of Science ®Google Scholar
• Khan, S. A., Ashraf, Z. K., Uddin, S., & Ul-Haq, R. (2020). Z. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach. Journal of Biomolecular Structure and Dynamics, 11, 1–10.
   Google Scholar
• Khodarahmi, G., Asadi, P., Farrokhpour, H., Hassanzadeh, F., & Dinari, M. (2015). Design of novel potential aromatase inhibitors via hybrid pharmacophore approach: Docking improvement using the QM/MM method. RSC Advances, 5(71), 58055–58064. https://doi.org/https://doi.org/10.1039/C5RA10097F
   Web of Science ®Google Scholar
• Kirchmair, J., Markt, P., Distinto, S., Wolber, G., & Langer, T. (2008). Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection-what can we learn from earlier mistakes? Journal of Computer-Aided Molecular Design, 22(3-4), 213–228.
   PubMed Web of Science ®Google Scholar
• Koča, J., Kříž, Z., & Carlsen, P. H. (1994). Computer study of conformational flexibility of 20 common amino acids. Journal of Molecular Structure: Theochem, 306(2-3), 157–164. https://doi.org/https://doi.org/10.1016/0166-1280(94)80036-7
   Google Scholar
• Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., Rollin, P. E., Dowell, S. F., Ling, A.-E., Humphrey, C. D., Shieh, W.-J., Guarner, J., Paddock, C. D., Rota, P., Fields, B., … Anderson, L. J. (2003). A novel coronavirus associated with severe acute respiratory syndrome. The New England Journal of Medicine, 348(20), 1953–1966.
   PubMed Web of Science ®Google Scholar
• Kumar, K. S., Rao, A. L., & Rao, M. B. (2018). Design, synthesis, biological evaluation and molecular docking studies of novel 3-substituted-5-[(indol-3-yl) methylene]-thiazolidine-2, 4-dione derivatives. Heliyon, 4(9), e00807.
   PubMed Web of Science ®Google Scholar
• Kumar, P., Choonara, Y. E., & Pillay, V. (2014). In silico affinity profiling of neuroactive polyphenols for post-traumatic calpain inactivation: A molecular docking and atomistic simulation sensitivity analysis. Molecules, 20(1), 135–168. https://doi.org/https://doi.org/10.3390/molecules20010135
   PubMed Web of Science ®Google Scholar
• Lalani, S., & Poh, C. L. (2020). Flavonoids as antiviral agents for Enterovirus A71 (EV-A71). Viruses, 12(2), 184. https://doi.org/https://doi.org/10.3390/v12020184
   PubMed Web of Science ®Google Scholar
• Lillie, P. J., Samson, A., Li, A., Adams, K., Capstick, R., Barlow, G. D., Easom, N., Hamilton, E., Moss, P. J., Evans, A., & Ivan, M. (2020). Novel coronavirus disease (Covid-19): The first two patients in the UK with person to person transmission. Journal of Infection. https://doi.org/https://doi.org/10.1016/j.jinf.2020.02.020
   Google Scholar
• Lin, L. C., Kuo, Y. C., & Chou, C. J. (2000). Cytotoxic biflavonoids from Selaginella delicatula. Journal of Natural Products, 63(5), 627–630.
   PubMed Web of Science ®Google Scholar
• Lin, Y. M., Flavin, M. T., Schure, R., Chen, F. C., Sidwell, R., Barnard, D. I., Huffmann, J. H., & Kern, E. R. (1999). Antiviral activities of biflavonoids. Planta Medica, 65(2), 120–125. https://doi.org/https://doi.org/10.1055/s-1999-13971
   PubMed Web of Science ®Google Scholar
• Lin, Y. M., Zembower, D. E., Flavin, M. T., Schure, R. M., Anderson, H. M., Korba, B. E., & Chen, F. C. (1997). Robustaflavone, a naturally occurring biflavanoid, is a potent non-nucleoside inhibitor of hepatitis B virus replication in vitro. Bioorganic & Medicinal Chemistry Letters, 7(17), 2325–2328. https://doi.org/https://doi.org/10.1016/S0960-894X(97)00422-8
   Web of Science ®Google Scholar
• Lipinski, C. A. (2000). Drug-like properties and the causes of poor solubility and poor permeability. Journal of Pharmacological and Toxicological Methods, 44(1), 235–249. https://doi.org/https://doi.org/10.1016/S1056-8719(00)00107-6
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A. (2004). Lead- and drug-like compounds: the rule-of-five revolution . Drug Discovery Today. Technologies, 1(4), 337–341.
   PubMedGoogle Scholar
• Liu, K., Tang, M., Liu, Q., Han, X., Jin, H., Zhu, H., Li, Y., He, L., Ji, H., & Zhou, B. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery, 6(1), 1–4. https://doi.org/https://doi.org/10.1038/s41421-020-0156-0
   PubMed Web of Science ®Google Scholar
• Liu, P., Chen, W., & Chen, J. P. (2019). Viral metagenomics revealed sendai virus and coronavirus infection of Malayan Pangolins (Manis javanica). Viruses, 11(11), 979. Novhttps://doi.org/https://doi.org/10.3390/v11110979
   PubMed Web of Science ®Google Scholar
• Lung, J., Lin, Y. S., Yang, Y. H., Chou, Y. L., Shu, L. H., Cheng, Y. C., Liu, H. T., & Wu, C. Y. (2020). The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase. Journal of Medical Virology, 92(6), 693–697. https://doi.org/https://doi.org/10.1002/jmv.25761
   PubMed Web of Science ®Google Scholar
• Meruelo, D., Lavie, G., & Lavie, D. (1988). Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudohypericin. Proceedings of the National Academy of Sciences of the United States of America, 85(14), 5230–5234.
   PubMed Web of Science ®Google Scholar
• Mesch, G. S., & Schwirian, K. P. (2019). Vaccination hesitancy: Fear, trust, and exposure expectancy of an Ebola outbreak. Heliyon, 5(7), e02016.
   PubMed Web of Science ®Google Scholar
• Miki, K., Nagai, T., Suzuki, K., Tsujimura, R., Koyama, K., Kinoshita, K., Furuhata, K., Yamada, H., & Takahashi, K. (2007). Anti-influenza virus activity of biflavonoids. Bioorganic & Medicinal Chemistry Letters, 17(3), 772–775.
   PubMed Web of Science ®Google Scholar
• Mirza, M. U., & Froeyen, M. (2020). Structural elucidation of SARS-CoV-2 vital proteins: Computational methods reveal potential drug candidates against main protease, Nsp12 polymerase and Nsp13 helicase. Journal of Pharmaceutical Analysis, 10(4), 320–328. https://doi.org/https://doi.org/10.1016/j.jpha2020.04.008]
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., & Olson, A. J. (1998). Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. Journal of Computational Chemistry, 19(14), 1639–1662. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14 < 1639::AID-JCC10 > 3.0.CO;2-B
   Web of Science ®Google Scholar
• Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand‐receptor docking. Current Protocols in Bioinformatics, 24(1), 8–14. https://doi.org/https://doi.org/10.1002/0471250953.bi0814s24
   Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.
   PubMed Web of Science ®Google Scholar
• Muralidharan, N., Sakthivel, R., Velmurugan, D., & Gromiha, M. M. (2020). Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 Protease against COVID-19. Journal of Biomolecular Structure and Dynamics, 14, 1–6.
   Web of Science ®Google Scholar
• Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012). Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking. Journal of Medicinal Chemistry, 55(14), 6582–6594.
   PubMed Web of Science ®Google Scholar
• Ñamendys-Silva, S. A. (2020). Respiratory support for patients with COVID-19 infection. The Lancet. Respiratory Medicine, 8(4), e18. https://doi.org/https://doi.org/10.1016/S2213-2600(20)30110-7
   PubMed Web of Science ®Google Scholar
• Ngoc, T. M., Phuong, N. T., Khoi, N. M., Park, S., Kwak, H. J., Nhiem, N. X., Trang, B. T., Tai, B. H., Song, J. H., Ko, H. J., & Kim, S. H. (2019). A new naphthoquinone analogue and antiviral constituents from the root of Rhinacanthus nasutus. Natural Product Research, 33(3), 360–366.
   PubMed Web of Science ®Google Scholar
• Odhar, H. A., Ahjel, S. W., Albeer, A. A., Hashim, A. F., Rayshan, A. M., & Humadi, S. S. (2020). Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus. Bioinformation, 16(3), 236–244.
   PubMed Web of Science ®Google Scholar
• Pant, S., Singh, M., Ravichandiran, V., Murty, U. S., & Srivastava, H. K. (2020). Peptide-like and small-molecule inhibitors against Covid-19. Journal of Biomolecular Structure and Dynamics, 1–10.
   PubMed Web of Science ®Google Scholar
• Patel, A., Hoffman, E., Ball, D., Klapwijk, J., Steven, R. T., Dexter, A., Bunch, J., Baker, D., Murnane, D., Hutter, V., Page, C., Dailey, L. A., & Forbes, B. (2019). Comparison of oral, intranasal and aerosol administration of amiodarone in rats as a model of pulmonary phospholipidosis. Pharmaceutics, 11(7), 345. https://doi.org/https://doi.org/10.3390/pharmaceutics11070345
   Web of Science ®Google Scholar
• Peng, X., Xu, X., Li, Y., Cheng, L., Zhou, X., & Ren, B. (2020). Transmission routes of 2019-nCoV and controls in dental practice. International Journal of Oral Science, 12(1), 9–6.
   PubMed Web of Science ®Google Scholar
• Perez, R. M. (2003). Antiviral activity of compounds isolated from plants. Pharmaceutical Biology, 41(2), 107–157. https://doi.org/https://doi.org/10.1076/phbi.41.2.107.14240
   Web of Science ®Google Scholar
• Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. H. (2016). An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy . Journal of Medicinal Chemistry, 59(14), 6595–6628.
   PubMed Web of Science ®Google Scholar
• Pu, X. Y., Liang, J. P., Wang, X. H., Xu, T., Hua, L. Y., Shang, R. F., Liu, Y., & Xing, Y. M. (2009). Anti-influenza A virus effect of Hypericum perforatum L. extract. Virologica Sinica, 24(1), 19–27. https://doi.org/https://doi.org/10.1007/s12250-009-2983-x
   Google Scholar
• Ravindranath, P. A., Forli, S., Goodsell, D. S., Olson, A. J., & Sanner, M. F. (2015). AutoDockFR: Advances in protein-ligand docking with explicitly specified binding site flexibility. PLoS Computational Biology, 11(12), e1004586.
   PubMed Web of Science ®Google Scholar
• Roccatano, D., Barthel, A., & Zacharias, M. (2007). Structural flexibility of the nucleosome core particle at atomic resolution studied by molecular dynamics simulation. Biopolymers, 85(5-6), 407–421.
   PubMed Web of Science ®Google Scholar
• Salazar-Bookaman, M. M., Wainer, I., & Patil, P. N. (1994). Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J Ocul Pharmacol, 10(1), 217–239.
   PubMedGoogle Scholar
• Sarma, P., Shekhar, N., Prajapat, M., Avti, P., Kaur, H., Kumar, S., Singh, S., Kumar, H., Prakash, A., Dhibar, D. P., & Medhi, B. (2020). In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain). Journal of Biomolecular Structure and Dynamics, 16, 1–9.
   Web of Science ®Google Scholar
• Schuck, A. G., Ausubel, M. B., Zuckerbraun, H. L., & Babich, H. (2008). Theaflavin-3,3'-digallate, a component of black tea: an inducer of oxidative stress and apoptosis. Toxicology in Vitro: An International Journal Published in Association with Bibra, 22(3), 598–609.
   PubMed Web of Science ®Google Scholar
• Shie, J. J., Fang, J. M., Kuo, C. J., Kuo, T. H., Liang, P. H., Huang, H. J., Yang, W. B., Lin, C. H., Chen, J. L., Wu, Y. T., & Wong, C. H. (2005). Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease. Journal of Medicinal Chemistry, 48(13), 4469–4473.
   PubMed Web of Science ®Google Scholar
• Silva Andrade, B., Ghosh, P., Barh, D., Tiwari, S., José Santana Silva, R., Rodrigues de Assis Soares, W., Silva Melo, T., Santos Freitas, A., González-Grande, P., Sousa Palmeira, L., Carlos Junior Alcantara, L., Giovanetti, M., Góes-Neto, A., & Ariston de Carvalho Azevedo, V. (2020). Computational screening for potential drug candidates against the SARS-CoV-2 main protease. F1000Research, 9(514), 514. 4https://doi.org/https://doi.org/10.12688/f1000research.23829.1
   Google Scholar
• Silva, A. R., Morais, S. M., Marques, M. M., Lima, D. M., Santos, S. C., Almeida, R. R., Vieira, I. G., & Guedes, M. I. (2011). Antiviral activities of extracts and phenolic components of two Spondias species against dengue virus. Journal of Venomous Animals and Toxins Including Tropical Diseases, 17(4), 406–413.
   Web of Science ®Google Scholar
• Singh, A. K., Singh, A., Shaikh, A., Singh, R., & Misra, A. (2020). Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes & Metabolic Syndrome, 14(3), 241–246.
   PubMed Web of Science ®Google Scholar
• Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2006). Protein-ligand docking: current status and future challenges. Proteins, 65(1), 15–26.
   PubMed Web of Science ®Google Scholar
• Verdonk, M. L., Berdini, V., Hartshorn, M. J., Mooij, W. T., Murray, C. W., Taylor, R. D., & Watson, P. (2004). Virtual screening using protein-ligand docking: Avoiding artificial enrichment. Journal of Chemical Information and Computer Sciences, 44(3), 793–806.
   PubMedGoogle Scholar
• Visalli, R. J., Ziobrowski, H., Badri, K. R., He, J. J., Zhang, X., Arumugam, S. R., & Zhao, H. (2015). Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase. Bioorganic & Medicinal Chemistry Letters, 25(16), 3168–3171.
   PubMed Web of Science ®Google Scholar
• Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995). LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein engineering, design and selection. Protein Engineering, 8(2), 127–134.
   PubMedGoogle Scholar
• Wallace, D. J., Gudsoorkar, V. S., Weisman, M. H., & Venuturupalli, S. R. (2012). New insights into mechanisms of therapeutic effects of antimalarial agents in SLE. Nature Reviews. Rheumatology, 8(9), 522–533.
   PubMed Web of Science ®Google Scholar
• Wen, C.-C., Kuo, Y.-H., Jan, J.-T., Liang, P.-H., Wang, S.-Y., Liu, H.-G., Lee, C.-K., Chang, S.-T., Kuo, C.-J., Lee, S.-S., Hou, C.-C., Hsiao, P.-W., Chien, S.-C., Shyur, L.-F., & Yang, N.-S. (2007). Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. Journal of Medicinal Chemistry, 50(17), 4087–4095.
   PubMed Web of Science ®Google Scholar
• Xu, G. H., Ryoo, I. J., Kim, Y. H., Choo, S. J., & Yoo, I. D. (2009). Free radical scavenging and antielastase activities of flavonoids from the fruits of Thuja orientalis. Archives of Pharmacal Research, 32(2), 275–282.
   PubMed Web of Science ®Google Scholar
• Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., Zhong, W., & Hao, P. (2020). Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Science China Life Sciences. Science China. Life Sciences, 63(3), 457–460. Mar-
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195.
   PubMed Web of Science ®Google Scholar
• Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., Chen, L., Shen, Y., Luo, M., Zuo, G., Hu, J., Duan, D., Nie, Y., Shi, X., Wang, W., … Xu, X. (2004). Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells. Journal of Virology, 78(20), 11334–1133 9.
   PubMed Web of Science ®Google Scholar
• Yu, R., Chen, L., Lan, R., Shen, R., & Li, P. (2020). Computational screening of antagonist against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. International Journal of Antimicrobial Agents, 56(2), 106012. https://doi.org/https://doi.org/10.1016/j.ijantimicag.2020.106012
   PubMed Web of Science ®Google Scholar
• Zakaryan, H., Arabyan, E., Oo, A., & Zandi, K. (2017). Flavonoids: Promising natural compounds against viral infections. Archives of Virology, 162(9), 2539–2551.
   PubMed Web of Science ®Google Scholar
• Zaki, A. M., Van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D., & Fouchier, R. A. (2012). Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England Journal of Medicine, 367(19), 1814–1820.
   PubMed Web of Science ®Google Scholar
• Zembower, D. E., Lin, Y. M., Flavin, M. T., Chen, F. C., & Korba, B. E. (1998). Robustaflavone, a potential non- nucleoside anti-hepatitis B agent. Antiviral Research, 39(2), 81–88.-https://doi.org/https://doi.org/10.1016/S0166-3542(98)00033-3
   PubMed Web of Science ®Google Scholar
• Zengion, A. H., & Yarnell, E. (2011). Herbal and nutritional supplements for painful conditions. InPain Procedures in Clinical Practice 2011 Jan 1. (pp. 187–204). Hanley & Belfus.
   Google Scholar
• Zhang, D. H., Wu, K. L., Zhang, X., Deng, S. Q., & Peng, B. (2020). In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 18(2), 152–158.
   PubMed Web of Science ®Google Scholar
• Zhang, T., Wu, Q., & Zhang, Z. (2020). Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak. Current Biology: Cb, 30(7), 1346–1351.e2.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Li, Y., Lin, B., Schroeder, M., & Huang, B. (2011). Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction. Bioinformatics (Oxford, England)), 27(15), 2083–2088.
   PubMed Web of Science ®Google Scholar
• Zhavoronkov, A., Aladinskiy, V., Zhebrak, A., Zagribelnyy, B., Terentiev, V., Bezrukov, D. S., Polykovskiy, D., Shayakhmetov, R., Filimonov, A., Orekhov, P., & Yan, Y. (2020). Potential COVID-2019 3C-like protease inhibitors designed using generative deep learning approaches. Insilico Medicine Hong Kong Ltd A, 307, E1.
   Google Scholar
• Zheng, X., & Polli, J. (2010). Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters. European Journal of Pharmaceutical Sciences, 41(1), 43–52. -https://doi.org/https://doi.org/10.1016/j.ejps.2010.05.013
   PubMed Web of Science ®Google Scholar
• Zoete, V., Grosdidier, A., & Michielin, O. (2009). Docking, virtual high throughput screening and in silico fragment-based drug design . Journal of Cellular and Molecular Medicine, 13(2), 238–248.
   PubMed Web of Science ®Google Scholar